Fundamental Analysis of CYREN LTD(NASDAQ:CYRN) stock

Fundamental Rating

Taking everything into account, CYRN scores 1 out of 10 in our fundamental rating. CYRN was compared to 276 industry peers in the Software industry. Both the profitability and financial health of CYRN have multiple concerns. CYRN is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CYRN has reported negative net income.

In the past year CYRN has reported a negative cash flow from operations.

In the past 5 years CYRN always reported negative net income.

CYRN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The profitability ratios for CYRN are negative, so there is not much use analyzing them.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 44.77%, CYRN is not doing good in the industry: 70.90% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of CYRN has declined.

The Profit Margin and Operating Margin are not available for CYRN so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	44.77%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5%

GM growth 5Y-5.47%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CYRN does not have a ROIC to compare to the WACC, probably because it is not profitable.

CYRN has less shares outstanding than it did 1 year ago.

Compared to 1 year ago, CYRN has an improved debt to assets ratio.

2.2 Solvency

CYRN has an Altman-Z score of -13.46. This is a bad value and indicates that CYRN is not financially healthy and even has some risk of bankruptcy.

CYRN's Altman-Z score of -13.46 is on the low side compared to the rest of the industry. CYRN is outperformed by 90.64% of its industry peers.

CYRN has a Debt/Equity ratio of 2.30. This is a high value indicating a heavy dependency on external financing.

CYRN has a worse Debt to Equity ratio (2.30) than 81.94% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	2.3
Debt/FCF	N/A
Altman-Z	-13.46

ROIC/WACCN/A

WACC3.12%

2.3 Liquidity

A Current Ratio of 1.29 indicates that CYRN should not have too much problems paying its short term obligations.

With a Current ratio value of 1.29, CYRN is not doing good in the industry: 65.22% of the companies in the same industry are doing better.

CYRN has a Quick Ratio of 1.29. This is a normal value and indicates that CYRN is financially healthy and should not expect problems in meeting its short term obligations.

CYRN has a Quick ratio of 1.29. This is in the lower half of the industry: CYRN underperforms 64.21% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.29
Quick Ratio	1.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.04% over the past year.

Looking at the last year, CYRN shows a very negative growth in Revenue. The Revenue has decreased by -13.53% in the last year.

Measured over the past years, CYRN shows a small growth in Revenue. The Revenue has been growing by 0.13% on average per year.

EPS 1Y (TTM)23.04%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q41.67%

Revenue 1Y (TTM)-13.53%

Revenue growth 3Y-4.58%

Revenue growth 5Y0.13%

Revenue growth Q2Q3.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CYRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CYRN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CYREN LTD

NASDAQ:CYRN (3/2/2023, 7:00:01 PM)

After market: 0.204 -0.01 (-6.51%)

0.2182

-0.06 (-20.65%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.75M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	44.77%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.71

Health

		Industry Rank	Sector Rank
Debt/Equity	2.3
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.29
Quick Ratio	1.29
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)23.04%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-13.53%

Revenue growth 3Y-4.58%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

CYREN LTD (CYRN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens